CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale SVP & Chief Scientific Officer sold 1,336 shares at $17.56 ($23,460)
- 4 Open-market sale Director sold 5,000 shares at $17.26 ($86,300)
- 4 Grant or award SVP & Chief Accounting Officer acquired 22,500 shares (grant or award)
- 4 Grant or award President & CEO acquired 67,500 shares (grant or award)
- 4 Grant or award SVP & Chief Operating Officer acquired 26,000 shares (grant or award)
- 4 Grant or award SVP & Chief Financial Officer acquired 26,000 shares (grant or award)
- 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 26,000 shares (grant or award)
- 4 Grant or award SVP & Chief Medical Officer acquired 15,000 shares (grant or award)
- 4 Grant or award SVP & Chief Scientific Officer acquired 10,500 shares (grant or award)
- 4 Open-market sale SVP & Chief Accounting Officer sold 100,000 shares at $15.09 ($1,509,000)
- 4 Open-market sale Director sold 5,000 shares at $14.10 ($70,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 5,000 shares at $15.50 ($77,500)
- 4 Open-market sale SVP & Chief Financial Officer sold 856 shares at $13.58 ($11,624)
- 4 Open-market sale President & CEO sold 2,170 shares at $13.58 ($29,469)
- 4 Open-market sale SVP & Chief Scientific Officer sold 339 shares at $13.58 ($4,604)
- 4 Open-market sale SVP & Chief Medical Officer sold 432 shares at $13.58 ($5,867)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 835 shares at $13.58 ($11,339)
- 4 Open-market sale SVP & General Counsel sold 836 shares at $13.58 ($11,353)
Page 25 of 49 · 970 filings